Progress in percutaneous management of coronary bifurcation lesions

Minerva Cardioangiologica

Volumn 53, Issue 5, 2005, Pages 379-401

  Dzavik V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Bifurcation; Percutaneous coronary intervention; Stents

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HIRULOG; PACLITAXEL; RAPAMYCIN; THROMBIN INHIBITOR; TRANILAST;

ACUTE CORONARY SYNDROME; ARTERY INTIMA PROLIFERATION; ATHERECTOMY; BALLOON DILATATION; CARDIOLOGIST; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; CYTOREDUCTIVE SURGERY; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; GUIDE WIRE; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; EQUIPMENT DESIGN; HUMANS; STENTS;

EID: 28444470542     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-83.
2. rd, Douglas JS Jr, Hollman J, Ischinger T et al. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984;53:10-4.
3. Renkin J, Wijns W, Hanet C, Michel X, Cosyns J, Col J et al. Angioplasty of coronary bifurcation stenoses: immediate and long-term results of the protecting branch technique. Cathet Cardiovasc Diagn 1991;22: 167-73.
4. Weinstein JS, Baim DS, Sipperly ME, McCabe CH, Lorell BH. Salvage of branch vessels during bifurcation lesion angioplasty: acute and long-term follow-up. Cathet Cardiovasc Diagn 1991;22:1-6.
5. Colombo A, Gaglione A, Nakamura S, Finci L. "Kissing" stents for bifurcational coronary lesion. Cathet Cardiovasc Diagn 1993;30:327-30.
6. Carrie D, Karouny E, Chouairi S, Puel J. "T"-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cathet Cardiovasc Diagn 1996;37:311-3.
7. Schwartz L, Morsi A. The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions. J Invasive Cardiol 2002;14:66-71.
8. Fort S, Lazzam C, Schwartz L. Coronary 'Y' stenting: a technique for angioplasty of bifurcation stenoses. Can J Cardiol 1996;12:678-82.
9. Teirstein PS. Kissing Palmaz-Schatz stents for coronary bifurcation stenoses. Cathet Cardiovasc Diagn 1996;37:307-10.
10. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Cathet Cardiovasc Diagn 1996;39:320-6.
11. Khoja A, Ozbek C, Bay W, Heisel A. Trouser-like stenting: a new technique for bifurcation lesions. Cathet Cardiovasc Diagn 1997;41:192-6; discussion 197-9.
12. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the "culotte" technique. Am J Cardiol 1998;82:943-9.
13. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, Corvaja N et al. Bifurcation lesions: two stents versus one stent-immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-51.
14. Gobeil F, Lefevre T, Guyon P, Louvard Y, Chevalier B, Dumas P et al. Stenting of bifurcation lesions using the Bestent: a prospective dual-center study. Catheter Cardiovasc Interv 2002;55:427-33.
15. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:929-36.
16. Garot P, Lefevre T, Savage M, Louvard Y, Bamlet WR, Willerson JT et al. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005;46: 606-12.
17. Dauerman HL, Higgins PJ, Sparano AM, Gibson CM, Garber GR, Carrozza JP Jr et al. Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. J Am Coll Cardiol 1998;32:1845-52.
18. Cervinka P, Foley DP, Sabate M, Costa MA, Serrano P, Ligthart JM et al. Coronary bifurcation stenting using dedicated bifurcation stents. Catheter Cardiovasc Interv 2000;49:105-11.
19. Lefevre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B et al. The FRONTIER stent registry safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am Coll Cardiol 2005;46:592-8.
20. van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J 2005;26:675-81.
21. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airoldi F et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv Oct 2003;60:145-51.
22. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, Steinheimer AM et al. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol 2004;94:913-7.
23. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
24. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-5.
25. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109:634-40.
26. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-9.
27. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004;109:1942-7.
28. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-64.
29. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
30. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-9.
31. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-7.
32. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-64.
33. Lim Po, Dzavik V. Balloon crush. Treatment of bifurcation lesions using the crush stenting technique as adapted for transradial approach of cutaneous coronary intervention. Catheter Cardiovasc Interv 2004;63:412-6.
34. Ge L, Iakovou I, Cosgrave J, Agostoni P, Airoldi F, Sangiorgi GM et al. Treatment bifurcation lesions with two stents: crush versus T Stenting - one year angiographic and clinical follow-up. Heart Jun 17 2005; [Epub ahead of print]
35. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon postdilation. J Am Coll Cardiol 2005;46:613-20.
36. Sharma SK. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv 2005;65:10-6.
37. Hoye A, van Mieghem CA, Ong AT, Aoki J, Rodriguez Granillo GA et al. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited. Int J Cardiovasc Intervent 2005;7: 36-40.
38. Ge L, Tsagalou E, Iakovou I, Sangiorgi GM, Corvaja N, Airoldi F et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:757-60.
39. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, Fujii K et al. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:599-605.
40. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004;94:115-8.
41. Lefevre T, Louvard Y, Morice MC, Loubeyre C, Piechaud JF, Dumas P. Stenting of bifurcation lesions: a rational approach. J Interv Cardiol 2001;14:573-85.
42. Ormiston JA, Currie E, Webster MW, Kay P, Ruygrok PN, Stewart JT et al. Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheter Cardiovasc Interv 2004;63:332-6.
43. Colombo A. Bifurcational lesions and the "crush" technique: understanding why it works and why it doesn't-a kiss is not just a kiss. Catheter Cardiovasc Interv 2004;63:337-8.
44. Ormiston JA, Webster MW, El Jack S, Ruygrok PN, Stewart JT, Scott D et al. Drug-eluting stents for coronary bifurcations: Bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv Jul 7 2005; [Epub ahead of print]
45. Stankovic G, Martini G, Ferraro M, Takagi T, Corvaja N, Albiero R et al. An In-Vitro Assessment of Stent Geometry for Bifurcation Lesions After Kissing Balloon Inflation. Am J Cardiol 2001;88:I-60G.
46. Colombo A, Stankovic G, Moses JW. Selection of coronary stents. J Am Coll Cardiol 2002;40:1021-33.
47. Kastrati A, Mehilli J, Schuhlen H, Dirschinger J, Dotzer F, ten Berg JM et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350: 232-8.
48. Kandzari DE, Berger PB, Kastrati A, Steinhubl SR, Mehilli J, Dotzer et al. Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization. J Am Coll Cardiol 2004;44:2133-6.
49. rd, Fry ET, DeLago A, Wilmer C et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20.